Filing Details
- Accession Number:
- 0001209191-10-061781
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-20 18:32:51
- Reporting Period:
- 2010-12-16
- Filing Date:
- 2010-12-20
- Accepted Time:
- 2010-12-20 18:32:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1145404 | Cornerstone Therapeutics Inc | CRTX | Pharmaceutical Preparations (2834) | 043523569 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1363558 | A Craig Collard | C/O Cornerstone Therapeutics Inc. 1255 Crescent Green Drive, Suite 250 Cary NC 27518 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-12-16 | 385,000 | $6.02 | 3,011,138 | No | 4 | S | Indirect | By Cornerstone BioPharma Holdings, Ltd. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Cornerstone BioPharma Holdings, Ltd. |
Footnotes
- Shares sold to Chiesi Farmaceutici SpA, ("Chiesi") at a price of $6.02 per share, pursuant to a stock purchase agreement dated December 16, 2010.
- The price was determined based on the average closing price of the Common Stock during the twenty days prior to the date of such sale.